SCHEMBL10110097

SCHEMBL10110097

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5cc6c7ccccc7oc6c6ccccc56)cc4)c4cccc5ccccc45)cc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.40
KDM4E B2RXH2 5/20 0.33
ALDH1A1 P00352 5/20 0.33
MAPT P10636 3/20 0.33
HPGD P15428 3/20 0.33
TSHR P16473 2/20 0.33
HSD17B10 Q99714 2/20 0.33
RAB9A P51151 2/20 0.33
AHR P35869 1/20 0.33
MAOB P27338 1/20 0.33
ALOX15 P16050 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
CYP1A1 P04798 4/20 0.33
CYP1A2 P05177 4/20 0.33
CYP1B1 Q16678 4/20 0.33
GGPS1 O95749 1/20 0.33
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
MAPK1 P28482 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10110286 0.94 ALOX5 (0.40) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL24586762 0.93 KDM4E (0.37) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL26165481 0.93 DYRK1A (0.35) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL24585819 0.93 DYRK1A (0.35) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL26165440 0.92 KDM4E (0.36) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL24585297 0.92 CYP1A1 (0.35) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL24585805 0.91 ALOX5 (0.38) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL24586686 0.91 PLA2G2A (0.34) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL22818137 0.91 ALOX5 (0.36) ALOX5KDM4EALDH1A1MAPTHPGD
SCHEMBL27337207 0.91 ALOX5 (0.41) ALOX5KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230123637-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-20 US disclosed
US-20220310930-A1 ORGANIC ELECTROLUMINESCENT ELEMENT EMITTING LIGHT AT HIGH LUMINOUS EFFICIENCY AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2022-09-29 US disclosed
US-9087997-B2 Aromatic amine derivative and organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-07-21 US disclosed
US-9087997-B2 Aromatic amine derivative and organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-07-21 US disclosed
US-8703304-B2 Aromatic amine derivative and organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-04-22 US disclosed
US-8703304-B2 Aromatic amine derivative and organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-04-22 US disclosed
US-20140061630-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-03-06 US disclosed
US-20140061630-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-03-06 US disclosed
US-20120161119-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-28 US disclosed
US-20120161119-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120161119-A1 AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE TYR, TERF2, SAT1 ALOX5 3505/4885KDM4E 522/4885ALDH1A1 452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.